Quentin S. Blackford
Mr. Blackford has served as a member of the Board of Directors since May 2019. He currently serves as the Chief Executive Officer of iRhythm Technologies, Inc. (NASDAQ: IRTC), a digital healthcare solutions company focused on the advancement of cardiac care. Before joining iRhythm, he served as Executive Vice President and Chief Financial Officer of Dexcom, Inc., a company that develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management, from September 2017 to October 2021. Prior to Dexcom he held several executive leadership positions with NuVasive, most recently Executive Vice President, Chief Financial Officer, head of strategy and corporate integrity from August 2016 to August 2017. Previous roles with NuVasive, a med-tech company that designs, develops, and markets products for the surgical treatment of spine disorders, include Executive Vice President and Chief Financial Officer from August 2014 to August 2016, Executive Vice President of Finance and Investor Relations from July 2012 to August 2014, and Vice President of Finance from January 2011 to June 2012. Prior to his roles at NuVasive, Mr. Blackford led the global financial planning & analysis group at Zimmer Holdings, Inc., in addition to serving as Director of Finance and Controller for the company’s Dental Division. He has served as an independent board member of Alphatec Holdings, Inc. since October 2017. Mr. Blackford earned Bachelor of Science degrees in Accounting and Business Administration from Grace College.